MedTrace Logo

Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients

NCT02844803 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-08-03

No results posted yet for this study

Summary

The study is a pilot trial to investigate the effect of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients.

Conditions

Interventions

DRUG

Combination of Metformin + S. Baicalensis

the combination therapy for 8 weeks

DRUG

Combination of Metformin + Placebo

the metformin single therapy for 8 weeks

Sponsors & Collaborators

  • Namyi Gu

    lead OTHER

Principal Investigators

  • Han Seok Choi, MD, PhD · Dongguk University College of Medicine and Ilsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844803 on ClinicalTrials.gov